Gemfibrozil
Pricing Report NDC 59762-0737-5

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Gemfibrozil (NDC 59762-0737-5) is $0.10991 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 17, 2022.

As a provided by Greenstone Llc, this medication is distributed in a 500 TABLET, FILM COATED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.10991
Per EA

Effective Date
Aug 17, 2022
Data Status
As of Aug 31, 2022
C/I - Chain or Independent Pharmacy
Package NDC
Description
500 TABLET, FILM COATED in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2021, the NADAC wholesale price for (NDC ) has moved within a range of $0.09822 to $0.11315 per EA. Over this 1 year and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0982 - $0.1132
Market Volatility
15.20% Variance
Latest Trend
11.90%
Date Unit Price Unit Source Method Rate
Aug 17, 2022 $0.10991 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 20, 2022 $0.09822 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 22, 2022 $0.10773 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 18, 2022 $0.10827 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 20, 2022 $0.10756 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 23, 2022 $0.10518 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 23, 2022 $0.10640 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 19, 2022 $0.10593 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 22, 2021 $0.10486 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 17, 2021 $0.10277 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 20, 2021 $0.10394 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 22, 2021 $0.10253 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 18, 2021 $0.10805 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 21, 2021 $0.10568 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 23, 2021 $0.10473 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 19, 2021 $0.10820 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 21, 2021 $0.10851 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 17, 2021 $0.10814 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 17, 2021 $0.10750 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 10, 2021 $0.11315 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026